Literature DB >> 24292684

CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing.

Y Yang1, R Liu1, R Qiu2, Y Zheng2, W Huang2, H Hu1, Q Ji1, H He3, Y Shang2, Y Gong1, Y Wang4.   

Abstract

Cullin 4B (CUL4B) is a component of the Cullin4B-Ring E3 ligase complex (CRL4B) that functions in proteolysis and is implicated in tumorigenesis. Here, we report that CRL4B is associated with histone methyltransferase SUV39H1, heterochromatin protein 1 (HP1) and DNA methyltransferases 3A (DNMT3A). We showed that CRL4B, through catalyzing H2AK119 monoubiquitination, facilitates H3K9 tri-methylation and DNA methylation, two key epigenetic modifications involved in DNA methylation-based gene silencing. Depletion of CUL4B resulted in loss of not only H2AK119 monoubiquitination but also H3K9 trimethylation and DNA methylation, leading to derepression of a collection of genes, including the tumor suppressor IGFBP3. We demonstrated that CUL4B promotes cell proliferation and invasion, which are consistent with a tumorigenic phenotype, at least partially by repressing IGFBP3. We found that the expression of CUL4B is markedly upregulated in samples of human cervical carcinoma and is negatively correlated with the expression of IGFBP3. Our experiments unveiled a coordinated action between histone ubiquitination/methylation and DNA methylation in transcription repression, providing a mechanism for CUL4B in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24292684     DOI: 10.1038/onc.2013.522

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  47 in total

1.  The cullin-4 complex DCDC does not require E3 ubiquitin ligase elements to control heterochromatin in Neurospora crassa.

Authors:  Keyur K Adhvaryu; Jordan D Gessaman; Shinji Honda; Zachary A Lewis; Paula L Grisafi; Eric U Selker
Journal:  Eukaryot Cell       Date:  2014-10-31

2.  H3K14 ubiquitylation promotes H3K9 methylation for heterochromatin assembly.

Authors:  Eriko Oya; Reiko Nakagawa; Yuriko Yoshimura; Mayo Tanaka; Gohei Nishibuchi; Shinichi Machida; Atsuko Shirai; Karl Ekwall; Hitoshi Kurumizaka; Hideaki Tagami; Jun-Ichi Nakayama
Journal:  EMBO Rep       Date:  2019-08-29       Impact factor: 8.807

3.  Suppression of autophagy during mitosis via CUL4-RING ubiquitin ligases-mediated WIPI2 polyubiquitination and proteasomal degradation.

Authors:  Guang Lu; Juan Yi; Andrea Gubas; Ya-Ting Wang; Yihua Wu; Yi Ren; Man Wu; Yin Shi; Chenxi Ouyang; Hayden Weng Siong Tan; Tianru Wang; Liming Wang; Nai-Di Yang; Shuo Deng; Dajing Xia; Ruey-Hwa Chen; Sharon A Tooze; Han-Ming Shen
Journal:  Autophagy       Date:  2019-03-30       Impact factor: 16.016

4.  FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells.

Authors:  Jia Z Shen; Zhixin Qiu; Qiulian Wu; Darren Finlay; Guillermina Garcia; Dahui Sun; Juha Rantala; William Barshop; Jennifer L Hope; Ryan C Gimple; Olle Sangfelt; Linda M Bradley; James Wohlschlegel; Jeremy N Rich; Charles Spruck
Journal:  Cell       Date:  2020-12-23       Impact factor: 41.582

5.  Deciphering the three-domain architecture in schlafens and the structures and roles of human schlafen12 and serpinB12 in transcriptional regulation.

Authors:  Jiaxing Chen; Leslie A Kuhn
Journal:  J Mol Graph Model       Date:  2019-04-09       Impact factor: 2.518

6.  Variants in CUL4B are associated with cerebral malformations.

Authors:  Anneke T Vulto-van Silfhout; Tadashi Nakagawa; Nadia Bahi-Buisson; Stefan A Haas; Hao Hu; Melanie Bienek; Lisenka E L M Vissers; Christian Gilissen; Andreas Tzschach; Andreas Busche; Jörg Müsebeck; Patrick Rump; Inge B Mathijssen; Kristiina Avela; Mirja Somer; Fatma Doagu; Anju K Philips; Anita Rauch; Alessandra Baumer; Krysta Voesenek; Karine Poirier; Jacqueline Vigneron; Daniel Amram; Sylvie Odent; Magdalena Nawara; Ewa Obersztyn; Jacek Lenart; Agnieszka Charzewska; Nicolas Lebrun; Ute Fischer; Willy M Nillesen; Helger G Yntema; Irma Järvelä; Hans-Hilger Ropers; Bert B A de Vries; Han G Brunner; Hans van Bokhoven; F Lucy Raymond; Michèl A A P Willemsen; Jamel Chelly; Yue Xiong; A James Barkovich; Vera M Kalscheuer; Tjitske Kleefstra; Arjan P M de Brouwer
Journal:  Hum Mutat       Date:  2015-01       Impact factor: 4.878

7.  CUL4B regulates autophagy via JNK signaling in diffuse large B-cell lymphoma.

Authors:  Ying Li; Xiangxiang Zhou; Ya Zhang; Juan Yang; Yangyang Xu; Yi Zhao; Xin Wang
Journal:  Cell Cycle       Date:  2019-02-01       Impact factor: 4.534

8.  The CUL4B-miR-372/373-PIK3CA-AKT axis regulates metastasis in bladder cancer.

Authors:  Xiaochen Liu; Jianfeng Cui; Li Gong; Fei Tian; Yangli Shen; Lipeng Chen; Yong Wang; Yangyang Xia; Lei Liu; Xiang Ye; Molin Wang; Guangyi Liu; Baichun Jiang; Changshun Shao; Yongxin Zou; Yaoqin Gong
Journal:  Oncogene       Date:  2020-03-03       Impact factor: 9.867

Review 9.  DNMT3A in haematological malignancies.

Authors:  Liubin Yang; Rachel Rau; Margaret A Goodell
Journal:  Nat Rev Cancer       Date:  2015-02-19       Impact factor: 60.716

10.  Knockdown of CUL4B inhibits proliferation and promotes apoptosis of colorectal cancer cells through suppressing the Wnt/β-catenin signaling pathway.

Authors:  Baoji Song; Hongjie Zhan; Quan Bian; Jiarui Li
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.